Charles Schwab’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.46M Sell
183,351
-10,804
-6% -$756K ﹤0.01% 2128
2025
Q4
$17.9M Buy
194,155
+1,021
+0.5% +$97.7K ﹤0.01% 1823
2025
Q3
$14.3M Sell
193,134
-90,466
-32% -$9.16M ﹤0.01% 1928
2025
Q2
$36.8M Sell
283,600
-4,292
-1% -$622K 0.01% 1287
2025
Q1
$45.9M Sell
287,892
-8,315
-3% -$1.5M 0.01% 1131
2024
Q4
$54.9M Buy
296,207
+15,042
+5% +$2.92M 0.01% 1064
2024
Q3
$59.3M Buy
281,165
+11,939
+4% +$2.07M 0.01% 997
2024
Q2
$36M Buy
269,226
+339
+0.1% +$64.2K 0.01% 1288
2024
Q1
$57.8M Buy
268,887
+4,949
+2% +$970K 0.01% 932
2023
Q4
$53.7M Buy
263,938
+7,716
+3% +$1.25M 0.01% 931
2023
Q3
$50.8M Buy
256,222
+7,838
+3% +$1.98M 0.01% 868
2023
Q2
$80.6M Sell
248,384
-59,653
-19% -$17M 0.02% 603
2023
Q1
$72.1M Buy
308,037
+986
+0.3% +$249K 0.02% 620
2022
Q4
$77.3M Buy
307,051
+19,203
+7% +$4.09M 0.02% 581
2022
Q3
$51.1M Buy
287,848
+76,956
+36% +$15.5M 0.02% 745
2022
Q2
$38.5M Sell
210,892
-2,763
-1% -$551K 0.01% 925
2022
Q1
$54.8M Buy
213,655
+10,579
+5% +$2.42M 0.02% 810
2021
Q4
$46.7M Buy
203,076
+4,592
+2% +$1.12M 0.01% 943
2021
Q3
$46.2M Buy
198,484
+2,023
+1% +$422K 0.02% 932
2021
Q2
$38M Buy
196,461
+4,128
+2% +$819K 0.01% 1069
2021
Q1
$39.8M Buy
192,333
+16,092
+9% +$3.42M 0.01% 983
2020
Q4
$33.1M Buy
176,241
+2,388
+1% +$390K 0.01% 1031
2020
Q3
$22.4M Buy
173,853
+44,418
+34% +$4.89M 0.01% 1130
2020
Q2
$11.3M Buy
129,435
+39,800
+44% +$3.06M 0.01% 1573
2020
Q1
$5.4M Buy
89,635
+1,915
+2% +$142K ﹤0.01% 1798
2019
Q4
$6.51M Buy
87,720
+3,197
+4% +$205K ﹤0.01% 1892
2019
Q3
$5.16M Buy
84,523
+9,591
+13% +$632K ﹤0.01% 1940
2019
Q2
$4.54M Sell
74,932
-146
-0.2% -$7.87K ﹤0.01% 2014
2019
Q1
$4.26M Buy
75,078
+8,650
+13% +$467K ﹤0.01% 2045
2018
Q4
$2.81M Buy
66,428
+22,789
+52% +$969K ﹤0.01% 2193
2018
Q3
$1.84M Buy
43,639
+2,952
+7% +$139K ﹤0.01% 2450
2018
Q2
$1.45M Buy
+40,687
New +$1.31M ﹤0.01% 2469

Other funds holding INSP